One application of antigen displaying VLP vaccine is the RTS,S (MosquirixTM) against malaria, which is based on the hepatitis B small surface antigen (HBsAg) particle displaying truncated circumsporozoite protein (CSP) antigen (Rts et al., 2012). This evidence concerns the gene DNAJC5 and malaria.